Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial.
about
Combination chemotherapy versus single-agent chemotherapy during preoperative chemoradiation for resectable rectal cancerRadiotherapy for Colorectal Cancer: Current Standards and Future PerspectivesA Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal CancerAdjuvant chemotherapy for rectal cancer: Is it needed?Management of colorectal cancerCurrent treatment of rectal cancer adapted to the individual patientNeoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancerReview of systemic therapies for locally advanced and metastatic rectal cancerCurrent debate in the oncologic management of rectal cancer.Past, present, and future of radiotherapy for the benefit of patientsSystematic review and meta-analysis of preoperative chemoradiotherapy with or without oxaliplatin in locally advanced rectal cancer.Evaluation of capecitabine and oxaliplatin administered prior to and then concomitant to radiotherapy in high risk locally advanced rectal cancer.Can dosimetric parameters predict acute hematologic toxicity in rectal cancer patients treated with intensity-modulated pelvic radiotherapy?Oxaliplatin/fluorouracil-based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta-analysis of randomized controlled trials.A multicenter phase I study of preoperative chemoradiotherapy with S-1 and irinotecan for locally advanced lower rectal cancer (SAMRAI-1)Pre-operative hyperfractionated concurrent radiochemotherapy for locally advanced rectal cancers: a phase II clinical study.Neoadjuvant therapy before surgical treatmentCapecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04Efficacy and short-term outcomes of preoperative chemoradiotherapy with intermittent oral tegafur-uracil plus leucovorin in Japanese rectal cancer patients: a single center experience retrospective analysis.Neoadjuvant chemotherapy in borderline resectable pancreatic cancer: A case report.The Prognostic Value of Tyrosine Kinase SRC Expression in Locally Advanced Rectal Cancer.Recent advances in gastrointestinal oncology--updates and insights from the 2009 annual meeting of the American society of clinical oncologyMeta-analysis of oxaliplatin-based versus fluorouracil-based neoadjuvant chemoradiotherapy and adjuvant chemotherapy for locally advanced rectal cancer.Effect of time interval between capecitabine intake and radiotherapy on local recurrence-free survival in preoperative chemoradiation for locally advanced rectal cancerAbdominoperineal excision following preoperative radiotherapy for rectal cancer: unfavorable prognosis even with negative circumferential resection marginNeoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study.Overview of radiation therapy for treating rectal cancer.Long-term results of a randomized trial in locally advanced rectal cancer: no benefit from adding a brachytherapy boost.Oxaliplatin-based adjuvant chemotherapy without radiotherapy can improve the survival of locally-advanced rectal cancerThe emerging role of neoadjuvant chemotherapy for rectal cancerThe role of capecitabine in locally advanced rectal cancer treatment: an update.Multiplexed protein signal pathway mapping identifies patients with rectal cancer that responds to neoadjuvant treatment.Neoadjuvant chemoradiation for distal rectal cancer: 5-year updated results of a randomized phase 2 study of neoadjuvant combined modality chemoradiation for distal rectal cancerPhase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer.Neoadjuvant radiotherapy for rectal cancer: meta-analysis of randomized controlled trials.Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery.Phase I/II study of neoadjuvant bevacizumab, erlotinib and 5-fluorouracil with concurrent external beam radiation therapy in locally advanced rectal cancerThymidylate synthase genotype-directed neoadjuvant chemoradiation for patients with rectal adenocarcinoma.Neoadjuvant-intensified treatment for rectal cancer: time to change?Diffusion-weighted magnetic resonance application in response prediction before, during, and after neoadjuvant radiochemotherapy in primary rectal cancer carcinoma.
P2860
Q24186443-7008664D-354C-4C7B-B985-33EBD606BA19Q26738806-1F310275-7FFE-477E-A3EF-0908BB577B1EQ26739607-6BF34FFA-F84E-4C7A-A6C7-C6A1D3FE1548Q26775099-7457ED8E-4A14-47A9-AB45-220B31804059Q26823550-E7E46D6C-4471-424B-884D-668B3F932B9AQ26824553-C4267DEA-CD9C-4EAE-80CB-B7E792AD1CD0Q27003878-309BC312-DDCF-43DE-8612-FD8C6C0571A8Q27021105-E1AD2EE7-48EB-4E3C-99E7-826B1BC38FD4Q28072948-8CDC9065-701F-47AD-89C5-87DFA0ED56CEQ28280008-C7D3A7D8-FBD1-4055-8115-612E44A5EACFQ30235044-74A156CD-F835-4FA8-B5A1-6710797D3D93Q33411783-FA77E227-7FFB-4834-B2F6-CD8F35B1ABF5Q33424898-DA068EE8-9476-402C-A975-C5C89617BC9EQ33432180-85945C29-5E66-4F56-A788-9263458CCBB6Q33433227-7D4F36D4-5877-4461-87E6-722A3D1264DAQ33441568-A3B739D0-775A-4200-AD12-D840B325A029Q33697924-C0C2FB6E-D927-404A-9EB3-0D2F4F2B2CD1Q33729092-BB9A5AF7-1785-4F09-A7C4-B7014838FC67Q33749847-7C346317-56AE-4BD2-9101-DDA8B50CF13BQ33750803-2132956B-5BC0-414C-89F0-8763B07913A3Q33776733-6703110A-BA98-4A15-A46E-0F79C47535DFQ33797364-DC7E307F-8CF4-4B29-B30F-63293FBE8FD4Q33798353-603B122D-EDA6-4CD3-9C12-2145E58C4BBBQ33919715-7993B194-49B1-46CF-AA1B-D65B56845AABQ33958747-EFA4CB3F-8C36-4DFD-B876-C6A955EC6CA7Q34006430-74B7DDF8-9CEC-42DA-91E6-137449E26241Q34136267-A48DA76E-BD3C-4854-BED0-5A59B3FD6F36Q34156692-EB2D70C9-149F-4E20-BCC1-CD3F2E92603EQ34226859-6D00B7EA-44A8-4B8E-AAA3-A388309DF4CFQ34234935-08064C96-FD87-4A16-96C1-FBDC916ABD77Q34276823-9E15C9EC-369E-420C-B3A2-B5603EB7CFD1Q34289736-8C5107F2-D072-45DA-A616-DB7C82582DE6Q34359506-B9253B20-67EE-498E-93FA-5B8D03C361AAQ34499632-36323456-F82A-415E-89A7-E4766D375C2FQ34655838-A68F5679-6EE7-452E-A23A-B6E0C80317A4Q34687101-6AA65177-11BA-4939-B341-E97F6B943B1BQ34737137-45E0B05C-C1B1-4128-A221-39DAFBC44342Q34743494-315383D4-DD43-40A3-9703-224A71D29ECCQ34743672-0A5460AF-7183-4AC2-A5E3-47DDAC465543Q34927668-CCF0409A-2860-412B-9A86-C30EA828F580
P2860
Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Primary tumor response to preo ...... 01 randomized phase III trial.
@ast
Primary tumor response to preo ...... 01 randomized phase III trial.
@en
Primary tumor response to preo ...... 01 randomized phase III trial.
@nl
type
label
Primary tumor response to preo ...... 01 randomized phase III trial.
@ast
Primary tumor response to preo ...... 01 randomized phase III trial.
@en
Primary tumor response to preo ...... 01 randomized phase III trial.
@nl
prefLabel
Primary tumor response to preo ...... 01 randomized phase III trial.
@ast
Primary tumor response to preo ...... 01 randomized phase III trial.
@en
Primary tumor response to preo ...... 01 randomized phase III trial.
@nl
P2093
P356
P1476
Primary tumor response to preo ...... 01 randomized phase III trial.
@en
P2093
Andrea Bonetti
Angiolo Tagliagambe
Anna Maria Bochicchio
Carlo Aschele
Carmine Pinto
Domenico Cristiano Corsi
Gabriele Luppi
Gerardo Rosati
Germana Chiaulon
Giovanni Ambrosini
P304
P356
10.1200/JCO.2010.34.4911
P407
P577
2011-05-23T00:00:00Z